|
About PPD
PPD is a leading global contract research organization (CRO) providing discovery, development and post-approval services as well as compound partnering programs. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 33 countries and more than 10,500 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a commitment to quality to help its clients and partners maximize returns on their R&D investments and accelerate the delivery of safe and effective therapeutics to patients.
Discovery sciences and compound partnering:
-
Biomarker services
-
Compound partnering — resources spanning the R&D
continuum to provide early compound assessment and development within a
proven, innovative compound partnering program
-
Piedmont Research Center (division of PPD) — specialized
anticancer preclinical lab services and consulting for preclinical-Phase III
Development services (pharma, biotech, medical device, government and academia):
-
Phase I clinic
-
Phase II-IV trial management and monitoring
-
Bioanalytical labs
-
Biomarker services
-
Biostatistics
-
cGMP labs
-
Data management
-
Global central labs
-
Interactive voice response systems
-
Medical affairs
-
Medical information
-
Medical writing
-
Patient recruitment and site enrollment
-
Pharmacovigilance and safety support
-
Program management
-
Regulatory management and dossier submissions
-
Post-approval services
-
Therapeutic and specialty groups
|
|
Clinical
